Cellectis (CLLS) EBT Margin (2015 - 2026)
Cellectis' EBT Margin came in at -301.61% for Q2 2026, down 395.20 percentage points from 93.60% a year earlier and down 148.76 percentage points from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) EBT Margin (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Cellectis reported EBT Margin of -10.39%, down 58.86 percentage points year-over-year; for FY2025, it was -93.24%, down 4.67 percentage points from FY2024.
- EBT Margin carries a five-year change of +140.83 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was -88.57% in FY2024 (+15337.13 pp), -15425.70% in FY2023 (-14911.37 pp), -514.32% in FY2022 (-195.51 pp) and -318.81% in FY2021 (-84.74 pp).
- The Q2 2026 figure represents the lowest quarterly EBT Margin since Q2 2024.
- Year-over-year, EBT Margin has declined for three consecutive quarters, with an average year-over-year change of +1388.90 percentage points over the last eight quarters.
- The fastest year-over-year change in EBT Margin over five years came in Q2 2024 (a gain of 16237.03 percentage points), and the weakest in Q2 2023 (a drop of 15098.74 percentage points).
- Business Quant data shows CLLS's EBT Margin at -152.85% (Q1 2026), -30.91% (Q4 2025) and 63.72% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 41.75% |
| 10 | Cellectis | 151.51 Mn | -601.88 Mn | - | -301.61% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -301.61% |
| Mar 31, 2026 | -152.85% |
| Dec 31, 2025 | -30.91% |
| Sep 30, 2025 | 63.72% |
| Jun 30, 2025 | 93.60% |
| Mar 31, 2025 | 22.20% |
| Dec 31, 2024 | 12.31% |
| Sep 30, 2024 | 47.54% |
| Jun 30, 2024 | -316.34% |
| Mar 31, 2024 | 257.33% |
| Dec 31, 2023 | -2,359.01% |
| Sep 30, 2023 | -9,114.84% |
| Jun 30, 2023 | -16,553.37% |
| Mar 31, 2023 | -12,574.82% |
| Dec 31, 2022 | -17.70% |
| Sep 30, 2022 | -13,354.29% |
| Jun 30, 2022 | -1,454.63% |
| Mar 31, 2022 | -337.48% |
| Dec 31, 2021 | -68.77% |
| Sep 30, 2021 | -509.72% |
API Access
Cellectis EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();